ACRS — Aclaris Therapeutics, Inc. stock price, charts and financials

QT61Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.98
+0.45+8.14%
OverviewShort InterestFilings
ACRSQT61Aclaris Therapeutics, Inc.·NASDAQ
5.98+8.14%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 05, 20264Statement of changes in beneficial ownership
Apr 28, 20268-KCurrent report
Apr 27, 20264Statement of changes in beneficial ownership
Apr 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026ARSAnnual report to shareholders
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 07, 2026SC 13GBeneficial ownership statement (passive)
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 17, 2026SC 13GBeneficial ownership statement (passive)
Mar 11, 20268-KCurrent report
Mar 10, 20268-KCurrent report
Mar 03, 20264Statement of changes in beneficial ownership
Feb 26, 20268-KCurrent report
#1 / 25 of 350
Page
▼
/ 14